Entry Detail


General Information

Database ID:TRD00322
Confidence:Median
Contents:>> tsRNA Information
>> tsRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference



tsRNA Information

tsRNA Name:tiRNA-1:34-Val-AAC-2
tsRNA Type:5'-tiRNA
Amino acid and Anticodon:ValAAC
Sequence:GTTTCCGTAGTGTAGTGGTCATCACGTTCGCCTA
Related Target:N/A
Predicted Target:CTNND2//ZBED2//CDYL2//HK2//KIAA1549//SLC12A5//UNC5A//STK36//TRIM29//GPC6
External Links:
MINTbase ID:tRF-34-79MP9P9MH57S1O
tRFdb ID:N/A

[1] gtRNAdb_ID:tRNA-Val-AAC-2-1
Anticodon:ValAAC
tRNA_number:trna15
Chromosome:5
Strand:-
Coordinate:Start Site(bp): 180615455        End Site(bp): 180615488



tsRNA Association Statistics

Total Associated Disease Number:2
More Information
Network:
(Display the first 15 nodes)



Disease Information

 MeSHDisease Ontology
Disease ID:D001749DOID:4006
Disease Name:Urinary Bladder Neoplasmsbladder urothelial carcinoma
Category:MeSHDisease Ontology
Type:Neoplasms//Urogenital Diseasesdisease of cellular proliferation//disease of anatomical entity
Define:Tumors or cancer of the URINARY BLADDER.A bladder carcinoma that has_material_basis_in transitional cells located_in the lining of the bladder.
Alias:Bladder Cancer//Bladder Neoplasms//Bladder Tumors//Cancer of Bladder//Cancer of the Bladder//Malignant Tumor of Urinary Bladder//Neoplasms, Bladder//Urinary Bladder Cancerbladder transitional cell carcinoma//transitional cell carcinoma of bladder//urinary bladder urothelial carcinoma//urothelial bladder carcinoma



Disease Association Statistics

Total Associated tsRNA Number:41
More Information
Network:
(Display the first 15 nodes)



Evidence Support

Strong Evidence:N/A
Weak Evidence:High-throughput sequencing//Data Mining



Reference

[1] PubMed ID:35456407
Disease Name:Urinary Bladder Neoplasms
Tissue:bladder
Dysfunction Pattern:Up-Regulation
Validated Method:High-throughput sequencing//Data Mining
Description:Compared with paracancerous tissue, in tumor tissue, tiRNA-1:33-Gly-GCC-1 (p-value < 0.01) and tRF-1:32-Gly-GCC-1 (p-value < 0.01) were significantly upregulated, and tRF-+1:T20-Ser-TGA-1 (p-value < 0.01) was significantly downregulated, while tiRNA-1:34-Val-CAC-2 (p-value = 0.0565) was overexpressed without reaching statistical significance.
Comparision:Tumor VS Paracancer
Mechanism:N/A